Scholarlink

Introduction <p>Pharmaceuticals in aquatic environments are a growing environmental concern. Because of their widespread use and poor removal by conventional wastewater treatment, benzodiazepines are frequently detected in treated effluents.</p> Objective <p>To synthesise global evidence on the occurrence and distribution of benzodiazepines and their metabolites across the urban water cycle.</p> Methods <p>The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed in performing this systematic review. Bibliographic databases PubMed (including PubMed Central and Medline), Embase and Scopus were searched, from the inception date to July 26th, 2024, using query terms related to benzodiazepines (BDZs) and water pollution. Titles, abstracts and full text of the articles were independently evaluated by six review authors.</p> Results <p>Of 1973 records identified, 119 studies published between 2001 and 2024 met the inclusion criteria. Most research (<i>N</i> = 102) was conducted in European countries, followed by Asia (<i>N</i> = 29), America (<i>N</i> = 16), Africa (<i>N</i> = 5) and Australia (<i>N</i> = 2). Reported BDZ concentrations varied widely across the included studies, ranging from below analytical detection limits to several thousand ng/L, depending on the specific compound, sampling strategy, analytical technique, and environmental matrix. Most of the included studies searched BDZs in surface water (<i>N</i> = 61), followed by wastewater treatment plants (WWTP) effluents (<i>N</i> = 47) and WWTP influents (<i>N</i> = 40). Diazepam (<i>N</i> = 64 studies), oxazepam (<i>N</i> = 58 studies), lorazepam (<i>N</i> = 45 studies), temazepam (<i>N</i> = 31 studies) and alprazolam (<i>N</i> = 29 studies) were the most frequently detected compounds.</p> Conclusion <p>Global data highlight the need for standardised monitoring frameworks, targeted sources mitigation, and advanced water treatment technologies capable of efficiently removing chemically stable pharmaceutical compounds. Strengthening these approaches is essential to reduce ecological risks, minimise human exposure, and safeguard the long-term integrity of aquatic ecosystems.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Presence of Benzodiazepines in Aquatic Environments: A Systematic Review of the Literature

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月21日

查看全文
  • Jacopo Grisotto,
  • Irene Cristini,
  • Salvatore Crisafulli,
  • Francesco Ciccimarra,
  • Francesca Patuzzi,
  • Federica Soardo,
  • Elisabetta Mariavittoria Giunco,
  • Giovanna Paolone,
  • Gianluca Trifirò

摘要

Introduction

Pharmaceuticals in aquatic environments are a growing environmental concern. Because of their widespread use and poor removal by conventional wastewater treatment, benzodiazepines are frequently detected in treated effluents.

Objective

To synthesise global evidence on the occurrence and distribution of benzodiazepines and their metabolites across the urban water cycle.

Methods

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed in performing this systematic review. Bibliographic databases PubMed (including PubMed Central and Medline), Embase and Scopus were searched, from the inception date to July 26th, 2024, using query terms related to benzodiazepines (BDZs) and water pollution. Titles, abstracts and full text of the articles were independently evaluated by six review authors.

Results

Of 1973 records identified, 119 studies published between 2001 and 2024 met the inclusion criteria. Most research (N = 102) was conducted in European countries, followed by Asia (N = 29), America (N = 16), Africa (N = 5) and Australia (N = 2). Reported BDZ concentrations varied widely across the included studies, ranging from below analytical detection limits to several thousand ng/L, depending on the specific compound, sampling strategy, analytical technique, and environmental matrix. Most of the included studies searched BDZs in surface water (N = 61), followed by wastewater treatment plants (WWTP) effluents (N = 47) and WWTP influents (N = 40). Diazepam (N = 64 studies), oxazepam (N = 58 studies), lorazepam (N = 45 studies), temazepam (N = 31 studies) and alprazolam (N = 29 studies) were the most frequently detected compounds.

Conclusion

Global data highlight the need for standardised monitoring frameworks, targeted sources mitigation, and advanced water treatment technologies capable of efficiently removing chemically stable pharmaceutical compounds. Strengthening these approaches is essential to reduce ecological risks, minimise human exposure, and safeguard the long-term integrity of aquatic ecosystems.